These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36721230)
1. Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data. Qiao P; Guo Q; Gao J; Ma D; Liu S; Gao X; Lu TH; Zhang L Arthritis Res Ther; 2023 Jan; 25(1):16. PubMed ID: 36721230 [TBL] [Abstract][Full Text] [Related]
2. Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis. Santo AH; Souza JM; Pinheiro CE; Souza DC; Sato EI BMC Public Health; 2010 Oct; 10():597. PubMed ID: 20937106 [TBL] [Abstract][Full Text] [Related]
3. Secular Trends in Systemic Sclerosis Mortality in the United States from 1981 to 2020. Li JX Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429809 [TBL] [Abstract][Full Text] [Related]
4. Mortality of Chinese patients with polymyositis and dermatomyositis. Yang X; Hao Y; Zhang X; Geng Y; Ji L; Li G; Zhang Z Clin Rheumatol; 2020 May; 39(5):1569-1579. PubMed ID: 31902027 [TBL] [Abstract][Full Text] [Related]
5. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Murray SG; Schmajuk G; Trupin L; Lawson E; Cascino M; Barton J; Margaretten M; Katz PP; Yelin EH; Yazdany J Arthritis Care Res (Hoboken); 2015 May; 67(5):673-80. PubMed ID: 25331828 [TBL] [Abstract][Full Text] [Related]
6. Prognosis and mortality of polymyositis and dermatomyositis patients. Airio A; Kautiainen H; Hakala M Clin Rheumatol; 2006 Mar; 25(2):234-9. PubMed ID: 16477398 [TBL] [Abstract][Full Text] [Related]
7. Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study. D'Silva KM; Li L; Lu N; Ogdie A; Avina-Zubieta JA; Choi HK Rheumatology (Oxford); 2021 Jun; 60(6):2653-2660. PubMed ID: 33175975 [TBL] [Abstract][Full Text] [Related]
8. Mortality trends in polymyositis and dermatomyositis: A general population-based study. Li L; D'Silva KM; Lu N; Huang K; Esdaile JM; Choi HK; Aviña-Zubieta JA Semin Arthritis Rheum; 2020 Oct; 50(5):834-839. PubMed ID: 32896696 [TBL] [Abstract][Full Text] [Related]
9. Interstitial lung disease in polymyositis and dermatomyositis. Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835 [TBL] [Abstract][Full Text] [Related]
10. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620 [TBL] [Abstract][Full Text] [Related]
11. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232 [TBL] [Abstract][Full Text] [Related]
12. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study. Wu C; Wang Q; He L; Yang E; Zeng X PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373 [TBL] [Abstract][Full Text] [Related]
13. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020 [TBL] [Abstract][Full Text] [Related]
14. Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. Yu KH; Wu YJ; Kuo CF; See LC; Shen YM; Chang HC; Luo SF; Ho HH; Chen IJ Clin Rheumatol; 2011 Dec; 30(12):1595-601. PubMed ID: 21915609 [TBL] [Abstract][Full Text] [Related]
15. Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023). Fares J; Summer R; Loizidis G Clin Rheumatol; 2024 Jan; 43(1):325-338. PubMed ID: 37930595 [TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality in adult polymyositis and dermatomyositis. Marie I Curr Rheumatol Rep; 2012 Jun; 14(3):275-85. PubMed ID: 22410829 [TBL] [Abstract][Full Text] [Related]
17. Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study. Maldonado F; Patel RR; Iyer VN; Yi ES; Ryu JH Respirology; 2012 Apr; 17(3):455-60. PubMed ID: 22085242 [TBL] [Abstract][Full Text] [Related]
18. Integrated therapy decreases the mortality of patients with polymyositis and dermatomyositis: A Taiwan-wide population-based retrospective study. Chang CM; Shih PH; Chen TJ; Ho WC; Yang CP J Ethnopharmacol; 2019 May; 236():70-81. PubMed ID: 30818007 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors. Ishizuka M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Fujii H; Harigae H Mod Rheumatol; 2016; 26(1):115-20. PubMed ID: 26011440 [TBL] [Abstract][Full Text] [Related]
20. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Maoz CR; Langevitz P; Livneh A; Blumstein Z; Sadeh M; Bank I; Gur H; Ehrenfeld M Semin Arthritis Rheum; 1998 Apr; 27(5):319-24. PubMed ID: 9572713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]